Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
See Latest ArticlesPlatelet Activating Factor/Platelet Activating Factor Receptor Pathway as a Potential Therapeutic Target in Autoimmune Diseases
Inflammation & Allergy - Drug Targets, 07/02/09
Edwards LJ et al. - Recent experiments from the laboratory show that PAF/PAF-R pathway may influence T cell responses and favour the Th17 phenotype. The PAF/PAF-R pathway is a promising target for pharmacological intervention in autoimmune diseases.
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: Evaluation of efficacy and tolerance
Journal of Clinical Oncology, 10/23/09
Update of the guidelines for lupus anticoagulant detection
Journal of Thrombosis and Haemostasis, 09/28/09
Romiplostim in chronic immune thrombocytopenic purpura
Clinical Therapeutics, 10/23/09
Today in Rheumatic/Autoimmune...keeping you current
Receive free subspecialty "5-minute updates" via email
Latent Autoimmune Diabetes in Adults
Journal of Clinical Endocrinology and Metabolism, 10/21/09
Will treatment of rheumatoid arthritis with an IL-6R inhibitor help facilitate the age of remission?
Expert Opinion on Investigational Drugs, 10/13/09
Vaccination, atherosclerosis and systemic lupus erythematosus
Lupus, 11/05/09
Sponsor
Article Search
Sponsor